Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its Concierge Medical business provides discreet and personalized concierge healthcare services, including IV Vitamin Therapy. Its services include Screenpro Security, Justera Health Product, Naturevan, Juillet Wellness, and TRINITI Corporation. It is also specialized in providing efficient COVID-19 testing and same-day test results through its Canadian labs. It offers two convenient methods to test: in clinic testing or mobile at home testing. It is a distributor of TonyMoly skin care products in Canada. It provides a full-service wellness center, providing a range of beauty and wellness services.


CSE:VTAL - Post by User

Post by bohemian62on May 05, 2021 3:44pm
160 Views
Post# 33134050

SCRN Longs will be rewarded !!

SCRN Longs will be rewarded !!

A vast pool of local industry participants and intense competition among players impact the buying behavior of consumers. The growing prevalence of chronic diseases is leading to an increase in the need for rapid disease diagnosis, which is further positively impacting the buying behavior process of rapid medical supplies for diagnostic applications.

The increasing prevalence of multidrug-resistant bacterial infections is set to propel the demand for rapid medical evaluation. Moreover, the outbreak of COVID-19 has created a significant opportunity for manufacturers to develop rapid diagnostic test supplies to contain the spread of COVID-19 infection. Expanding population, genetic variation in hosts and pathogens, and environmental change are some of the aspects contributing to the increased demand for rapid medical supplies, thereby boosting the industry expansion.

Contrastingly, with the advent of advanced technologies, such as lab-based PCR and molecular diagnostics, the demand for rapid diagnostic tests is expected to observe a sluggish growth. Although rapid diagnostic tests have high sensitivity and specificity for detecting malaria, PCR and molecular diagnostic technologies have proved to be more sensitive. Thus, infectious disease diagnosis has been revolutionized through advanced molecular techniques, such as PCR, which may emerge as a threat to the market.

Product Insights

Over the counter (OTC) kits dominated the market in 2020 with a share of 54.3%. This is attributed to the fact that these tests are easy to use in the “near-patient setting” and are a cost-effective alternative to expensive laboratory testing. These tests are typically used in home care settings, providing an easy and cost-effective alternative to laboratory testing. Rapid Diagnostic Tests (RDTs) commonly make use of saliva, urine, and blood to diagnose diseases.

According to the Consumer Healthcare Products Association, clinical cost savings amounted to over USD 77 billion owing to the low pricing of OTC diagnostic products. These tests also aid in the detection of various infectious and chronic diseases with limited or no symptoms, facilitating early treatment and reducing other complications associated with the disease. While these tests are most often used in home care settings, these tests are also used in hospitals, clinics, and diagnostic laboratories.

Professional rapid diagnostic test kits accounted for a significant revenue share in 2020. These tests most often make use of techniques, such as PCR and molecular diagnostics, providing higher test sensitivity and specificity. Professional laboratory tests are typically performed after a positive RDT has been obtained to confirm disease diagnosis. As RDTs have low sensitivity, they often provide false negatives, thus the use of professional tests is considered to be the gold standard in diagnostic settings.

<< Previous
Bullboard Posts
Next >>